KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Novavax (NVAX) over the last 7 years, with Q3 2025 value amounting to $168.2 million.

  • Novavax's Shares Outstanding (Diluted Average) rose 508.97% to $168.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $168.2 million, marking a year-over-year increase of 508.97%. This contributed to the annual value of $152.2 million for FY2024, which is 5103.01% up from last year.
  • As of Q3 2025, Novavax's Shares Outstanding (Diluted Average) stood at $168.2 million, which was up 508.97% from $177.4 million recorded in Q2 2025.
  • Novavax's 5-year Shares Outstanding (Diluted Average) high stood at $177.6 million for Q1 2025, and its period low was $73.0 million during Q1 2021.
  • For the 5-year period, Novavax's Shares Outstanding (Diluted Average) averaged around $113.0 million, with its median value being $100.8 million (2023).
  • As far as peak fluctuations go, Novavax's Shares Outstanding (Diluted Average) skyrocketed by 472.14% in 2022, and later soared by 6239.47% in 2024.
  • Over the past 5 years, Novavax's Shares Outstanding (Diluted Average) (Quarter) stood at $74.4 million in 2021, then grew by 5.08% to $78.2 million in 2022, then rose by 28.89% to $100.8 million in 2023, then skyrocketed by 51.03% to $152.2 million in 2024, then grew by 10.52% to $168.2 million in 2025.
  • Its last three reported values are $168.2 million in Q3 2025, $177.4 million for Q2 2025, and $177.6 million during Q1 2025.